Elosua v. Novo Nordisk A/S et al
| CAREN ELOSUA |
| Novo Nordisk A/S, Novo Nordisk North America Operations A/S, Novo Nordisk US Holdings, Inc., Novo Nordisk US Commercial Holdings, Inc., Novo Nordisk, Inc., Novo Nordisk Research Center Seattle, Inc., NOVO HOLDINGS A/S, NOVO HOLDINGS EQUITY US INC, NOVO VENTURES US, INC., Novo Nordisk Pharma, Novo Holdings Equity US Inc. and Novo Nordisk Pharmaceutical Industries LP. |
| 2:2024cv01841 |
| March 12, 2024 |
| US District Court for the Eastern District of New York |
| Steven Tiscione |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 Diversity-Product Liability |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 5, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Case transferred from New York Eastern has been opened in the Eastern District of Pennsylvania as case 2:24-cv-01394, filed 04/04/2024. (GO) |
| Filing 7 CERTIFIED JPMDL Conditional Transfer Order (CTO-8) IN RE: GLUCAGON-LIKE PEPTIDE-I RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION MDL No. 3094: Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. 1407 to the Eastern District of Pennsylvania for the reasons stated in the order of February 2, 2024, and, with the consent of that court, assigned to the Honorable Gene E.K. Pratter. (GO) |
| Filing 6 JPMDL Conditional Transfer Order (CTO-8): Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. 1407 to the Eastern District of Pennsylvania for the reasons stated in the order of February 2, 2024, and, with the consent of that court, assigned to the Honorable Gene E.K. Pratter. This order does not become effective until it is filed in the Office of the Clerk of the United States District Court for the Eastern District of Pennsylvania. (LF) |
| Case electronically transferred to the Eastern District of Pennsylvania. Original file, certified copy of transfer order, and docket sheet sent. ALL FILINGS ARE TO BE MADE IN THE TRANSFER COURT, DO NOT DOCKET TO THIS CASE. (GO) |
| Filing 5 AFFIDAVIT of Service for Summons and Complaint served on Novo Nordisk Inc. on March 27, 2024, filed by Caren Elosua. (Silverman, Craig) |
| Filing 4 Summons Issued as to All Defendants. (LJ) |
| Filing 3 Clerks Notice Re: Consent. A magistrate judge has been assigned as the presiding judge in this case as part of a Pilot Program, governed by EDNY Administrative Order 2023-23. In accordance with Rule 73 of the Federal Rules of Civil Procedure, Local Rule 73.1, the parties are notified that if all parties consent, the assigned Magistrate Judge is available to conduct all proceedings in this action including a (jury or nonjury) trial and to order the entry of a final judgment. Attached to this Notice is a blank copy of the consent form that should be filled out, signed and filed electronically only if all parties wish to consent. The form is also available here: #https://www.nyed.uscourts.gov/edny-direct-assignment-pilot-program. Any party may withhold its consent without adverse substantive consequences. Do NOT return or file the consent unless all parties have signed the consent. Unless all parties consent to the Magistrate Judge jurisdiction by the deadline set forth in the Administrative Order 2023-23, a District Judge will be assigned to the case. The parties are directed to review the terms of Administrative Order 2023-23 and other materials related to the Pilot Program on the Courts website: #https://www.nyed.uscourts.gov/edny-direct-assignment-pilot-program. (LJ) |
| Filing 2 This attorney case opening filing has been checked for quality control. See the attachment for corrections that were made. (LJ) |
| Case Assigned to Magistrate Judge Steven Tiscione. Please download and review the Individual Practices of the assigned Judges, located on our #website. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. (LJ) |
| Filing 1 COMPLAINT against Novo Holdings A/S, Novo Holdings Equity US Inc., Novo Ventures US, Inc., Novo Nordisk A/S, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries LP., Novo Nordisk Research Center Seattle, Inc., Novo Nordisk US Commercial Holdings, Inc., Novo Nordisk US Holdings, Inc., Novo Nordisk, Inc. filing fee $ 405, receipt number ANYEDC-17661122 Was the Disclosure Statement on Civil Cover Sheet completed -NO,, filed by Caren Elosua. (Attachments: #1 Civil Cover Sheet, #2 Proposed Summons) (Silverman, Craig) Modified on 3/13/2024 (LJ). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
